Artikel
Low-energy light treatment of wet AMD after completion of standard anti-VEGF therapy
Suche in Medline nach
Autoren
-
Andrii Serhiienko
- Vinnitsa/UA
-
O. Pekaryk
- Winnipeg/CDN
-
N. Dziuba
- City Hospaital #9, Kyiv/UA
| Veröffentlicht: | 5. Februar 2020 |
|---|
Gliederung
Text
Purpose: To evaluate the efficacy of the new approach to stabilizing deterioration of a state of the retina and visual functions in patients with wet AMD who had already completed the initial course of anti-VEGF therapy.
Material and Methods: 103 patients with exudative AMD after performing the anti-VEGF therapy were included in the study. The patients were divided into two groups. In the test group (62 patients) the low-energy light therapy was performed using the Spektra Light Device (Vision Aid Inc., Winnipeg, Canada). In the control group (41 patients) the only anti-VEGF therapy was applied.
Results: In the test group a rise of the visual acuity was from 30.0 ±4.22 to 32.58±4.33 letters and in the control group a decreasing of visual acuity from 35.77±5.82 to 19.34±4.33 letters. In the test group, a diminishing of the fovea thickness from 304.42±7.39 microns to 259.29±9.12 microns were found. In patients of the control group, an increase of the retinal thickness in the fovea area was registered from 279.84±8.63 to 392.89±14.82 microns.
Conclusion: Performing of low-energy light therapy to the patients with wet AMD after injections of anti-VEGF treatment resulted in stabilizing of visual acuity and improving the retina state.
